Clinical Trials Sponsored by Intarcia Therapeutics
Total 6321 results
-
Celldex TherapeuticsCompletedGlioblastoma | Gliosarcoma | Small Cell Glioblastoma | Giant Cell Glioblastoma | Glioblastoma With Oligodendroglial ComponentUnited States, Canada, Australia, Israel, Taiwan, United Kingdom, Belgium, France, Spain, Germany, Austria, Brazil, Colombia, Czechia, Greece, Hungary, India, Italy, Mexico, Netherlands, New Zealand, Peru, Switzerland, Thailand
-
Celldex TherapeuticsCompletedMalignant GliomaUnited States
-
Boston TherapeuticsCompletedPostprandial Hyperglycemia
-
Boston TherapeuticsCompletedPostprandial Hyperglycemia
-
PTC TherapeuticsCompleted
-
Abide TherapeuticsCompletedTourette Syndrome | Chronic Motor Tic DisorderGermany
-
Balance TherapeuticsCompletedMolecular Mechanisms of Pharmacological ActionUnited Kingdom
-
Summit TherapeuticsCompletedClostridium Difficile InfectionUnited Kingdom, United States, Czechia
-
Agile TherapeuticsCompletedContraceptionUnited States
-
Abide TherapeuticsTerminated
-
Acorda TherapeuticsCompletedMuscle Spasticity | Spinal Cord InjuryUnited States, Canada
-
PTC TherapeuticsCompletedDuchenne Muscular DystrophyUnited States
-
Amicus TherapeuticsCompleted
-
Wellstat TherapeuticsCompletedHereditary Orotic AciduriaUnited States
-
Celldex TherapeuticsCompletedAdvanced CancerUnited States
-
Corcept TherapeuticsTerminatedPsychosis | Psychotic Depression | Severe Major Depression With Psychotic FeaturesUnited States
-
Noven TherapeuticsCompleted
-
Noven TherapeuticsCompleted
-
Noven TherapeuticsCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Celldex TherapeuticsTerminatedUnresectable Stage III or Stage IV MelanomaUnited States
-
Osiris TherapeuticsTerminatedDiabetic Foot UlcersUnited States
-
Acorda TherapeuticsCompleted
-
Aerpio TherapeuticsCompleted
-
Therapeutics, Inc.CompletedA Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305)Plaque PsoriasisUnited States
-
Acorda TherapeuticsCompletedParkinson's DiseaseUnited States
-
Argos TherapeuticsCompletedKidney Cancer | Renal Cell Carcinoma | Advanced Renal Cell CarcinomaUnited States
-
Cytori TherapeuticsCompletedOsteoarthritis, KneeUnited States
-
UVLrx TherapeuticsCompletedQuality of Life | FatigueUnited States
-
Lumen TherapeuticsTerminated
-
Acorda TherapeuticsCompleted
-
BIND TherapeuticsCompletedNon-small Cell Lung CancerUnited States, Russian Federation
-
Wellstat TherapeuticsApproved for marketing
-
United TherapeuticsTerminatedPulmonary Arterial HypertensionAustralia
-
Centrexion TherapeuticsTerminatedAcute-onset Herpes Zoster PainAustralia
-
Chelsea TherapeuticsTerminatedParkinson's Disease | Pure Autonomic Failure | Dopamine Beta Hydroxylase Deficiency | Symptomatic Neurogenic Orthostatic Hypotension | Multiple Systems AtrophyUnited States
-
Resolve TherapeuticsCompletedSystemic Lupus ErythematosusUnited States
-
Noven TherapeuticsCompleted
-
Noven TherapeuticsCompleted
-
United TherapeuticsCompleted
-
Heron TherapeuticsCompletedHealthyUnited States
-
Arno TherapeuticsUnknownRecurrent Prostate Cancer | Prostate Cancer | Metastatic Prostate Cancer | Androgen-independent Prostate CancerUnited Kingdom
-
Io TherapeuticsCompleted
-
Sangamo TherapeuticsCompletedHIV Infections | HIV InfectionUnited States
-
vTv TherapeuticsCompleted
-
Mateon TherapeuticsCompleted
-
Halozyme TherapeuticsCompletedDiabetes Mellitus, Type IIUnited States
-
United TherapeuticsWithdrawn
-
Halozyme TherapeuticsCompleted
-
Halozyme TherapeuticsCompleted